Carter Percy H. - Insider Non-Derivative Transactions at Blueprint Medicines Corp (BPMC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jul 17, 2025, Carter Percy H.'s relationship to Blueprint Medicines Corp (BPMC) is Officer (Chief Scientific Officer), and currently has 74,508 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BPMC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Carter Percy H. - Insider Non-Derivative Transactions of BPMC Common Stock

Carter Percy H. - Insider Non-Derivative Transactions at BPMC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jul 18, 2025	U -- (Common Stock)	17894	0	0
Jul 18, 2025	Disposition -- (Common Stock)	56614	0	17894
Jul 18, 2025	Acquisition -- (Common Stock)	21353	0	74508
Jul 4, 2025	Sell -- (Common Stock)	1051	128.25	53155
Jun 4, 2025	Sell -- (Common Stock)	2418	127.88	54206
Jun 4, 2025	Sell -- (Common Stock)	241	127.88	56624
Mar 6, 2025	Sell -- (Common Stock)	3530	88.8	56865
Mar 2, 2025	Acquisition -- (Common Stock)	11000	0	60395
Jul 2, 2024	Acquisition -- (Common Stock)	7500	0	49395
Jun 6, 2024	Sell -- (Common Stock)	4000	105.13	41895
Jun 4, 2024	Sell -- (Common Stock)	2436	106.43	45895
Mar 8, 2024	Sell -- (Common Stock)	2286	90.69	48331
Mar 2, 2024	Acquisition -- (Common Stock)	12500	0	50617
Jun 6, 2023	Sell -- (Common Stock)	2307	52.06	38117
Mar 7, 2023	Sell -- (Common Stock)	25	44.78	40424
Mar 7, 2023	Sell -- (Common Stock)	736	45.72	40449
Mar 2, 2023	Acquisition -- (Common Stock)	12500	0	41185